We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRO icon
3926
Spero Therapeutics
SPRO
$71.8M
$15.3K ﹤0.01%
1,439
+8
+0.6% +$84
APHA
3927
DELISTED
Aphria Inc. Common Shares
APHA
$15.2K ﹤0.01%
2,929
+100
+4% +$635
NINE
3928
DELISTED
Nine Energy Service
NINE
$15.1K ﹤0.01%
2,449
-40
-2% -$392
IHI icon
3929
iShares US Medical Devices ETF
IHI
$3.48B
$15.1K ﹤0.01%
366
-132
-27% -$5.4K
ACET icon
3930
Adicet Bio
ACET
$77.3M
$15.1K ﹤0.01%
15
+6
+67% +$6.7K
GALT icon
3931
Galectin Therapeutics
GALT
$356M
$15K ﹤0.01%
4,099
+4,016
+4,839% +$14.5K
CFMS
3932
DELISTED
Conformis, Inc. Common Stock
CFMS
$15K ﹤0.01%
322
+317
+6,340% +$19.1K
CBFV icon
3933
CB Financial Services
CBFV
$190M
$15K ﹤0.01%
540
KBE icon
3934
State Street SPDR S&P Bank ETF
KBE
$1.75B
$15K ﹤0.01%
347
-15,694
-98% -$669K
WF icon
3935
Woori Financial
WF
$17.2B
$14.9K ﹤0.01%
478
-615
-56% -$19.6K
MTEM
3936
DELISTED
Molecular Templates, Inc.
MTEM
$14.8K ﹤0.01%
149
+34
+30% +$3.17K
PACD
3937
DELISTED
Pacific Drilling S.A. Common Shares
PACD
$14.7K ﹤0.01%
3,771
+2,332
+162% +$16.4K
SB icon
3938
Safe Bulkers
SB
$781M
$14.7K ﹤0.01%
8,380
+98
+1% +$191
TRP icon
3939
TC Energy
TRP
$65.8B
$14.6K ﹤0.01%
282
SMTA
3940
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$14.5K ﹤0.01%
1,723
-5,499
-76% -$46.5K
XOMA
3941
DELISTED
Xoma
XOMA
$14.5K ﹤0.01%
737
HOV icon
3942
Hovnanian Enterprises
HOV
$799M
$14.5K ﹤0.01%
754
SENS icon
3943
Senseonics Holdings Inc
SENS
$409M
$14.5K ﹤0.01%
734
+235
+47% +$5.7K
FSFG
3944
DELISTED
First Savings Financial Group
FSFG
$14.5K ﹤0.01%
687
LITS
3945
Lite Strategy Inc
LITS
$30.5M
$14.5K ﹤0.01%
430
+421
+4,678% +$15.3K
NGVC icon
3946
Vitamin Cottage Natural Grocers
NGVC
$646M
$14.4K ﹤0.01%
1,444
-186
-11% -$1.85K
LOGC
3947
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$14.4K ﹤0.01%
1,334
+371
+39% +$3.97K
CBAN icon
3948
Colony Bankcorp
CBAN
$471M
$14.4K ﹤0.01%
939
+581
+162% +$9.38K
ING icon
3949
ING
ING
$102B
$14.4K ﹤0.01%
1,374
+470
+52% +$4.94K
ORN icon
3950
Orion Group Holdings
ORN
$392M
$14.3K ﹤0.01%
3,179

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.